Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned GPI during primary percutaneous coronary intervention in acute myocardial infarction a VALIDATE-SWEDEHEART substudy

• Published in: European heart journal. Cardiovascular pharmacotherapy Vol. 6; no. 1; p. 6
• Main Authors: Sharma, Tania, Rylance, Rebecca, Karlsson, Sofia, Koul, Sasha, Venetsanos, Dimitrios, Omerovic, Elmir, Fröbert, Ole, Persson, Jonas, James, Stefan, Erlinge, David
• Format: Journal Article
• Language: English
• Published: 2020
• Subjects: Activated clotting time; Cardiology and Cardiovascular Disease; Heparin; Kardiologi och kardiovaskulära sjukdomar; NSTEMI; PCI; STEMI

Aims: Heparin is the preferred choice of anticoagulant in percutaneous coronary intervention (PCI) for acute myocardial infarction (MI). An established dosage of heparin has not yet been determined, but treatment may be optimized through monitoring of activating clotting time (ACT). The aim of this...